Low-density lipoprotein cholesterol targeting: a continued controversy.

Suppr

超能文献

作者信息

Whayne Thomas F

机构信息

1Division of Cardiovascular Medicine, Gill Heart Institute, University of Kentucky, Lexington, KY, USA.

出版信息

Angiology. 2014 Mar;65(3):263-4. doi: 10.1177/0003319713508641. Epub 2013 Oct 31.

DOI:10.1177/0003319713508641

PMID:24176912

Abstract

摘要

相似文献

Low-density lipoprotein cholesterol targeting: a continued controversy.

Angiology. 2014 Mar;65(3):263-4. doi: 10.1177/0003319713508641. Epub 2013 Oct 31.

Treat-to-target low-density lipoprotein cholesterol: time to debate a too simple and dogmatic paradigm.

Angiology. 2014 Mar;65(3):261-2. doi: 10.1177/0003319713507331. Epub 2013 Oct 24.

Translating AHA/ACC cholesterol guidelines into meaningful risk reduction.

J Fam Pract. 2019 May;68(4):206;210;212;214;217;221B.

Assessment of low-density lipoprotein targets.

Angiology. 2013 Aug;64(6):411-6. doi: 10.1177/0003319712451115. Epub 2012 Jun 25.

Individualized Risk Communication and Outreach for Primary Cardiovascular Disease Prevention in Community Health Centers: Randomized Trial.

Circ Cardiovasc Qual Outcomes. 2015 Nov;8(6):560-6. doi: 10.1161/CIRCOUTCOMES.115.001723. Epub 2015 Nov 10.

Prevention: HOPE-3 trial - targeting BP and LDL-C in at-risk patients.

Nat Rev Cardiol. 2016 May 16;13(6):315-6. doi: 10.1038/nrcardio.2016.74.

Statins for primary prevention: identifying low-risk individuals.

Nat Rev Cardiol. 2013 Sep;10(9):547. doi: 10.1038/nrcardio.2013.80-c1. Epub 2013 Jul 23.

Statins for primary prevention: problems with cardiovascular-risk estimation?

Nat Rev Cardiol. 2013 Sep;10(9):547. doi: 10.1038/nrcardio.2013.80-c2. Epub 2013 Jul 23.

Starting statins for primary prevention of cardiovascular disease.

Heart. 2013 Nov;99(21):1547-8. doi: 10.1136/heartjnl-2013-304284. Epub 2013 Jul 22.

Event reduction: revisiting why we treat with statins and harnessing current evidence towards optimal therapy.

Expert Opin Pharmacother. 2011 Jan;12(1):99-117. doi: 10.1517/14656566.2010.516747. Epub 2010 Nov 26.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Low-density lipoprotein cholesterol targeting: a continued controversy.

Angiology. 2014 Mar;65(3):263-4. doi: 10.1177/0003319713508641. Epub 2013 Oct 31.

Treat-to-target low-density lipoprotein cholesterol: time to debate a too simple and dogmatic paradigm.

Angiology. 2014 Mar;65(3):261-2. doi: 10.1177/0003319713507331. Epub 2013 Oct 24.

Translating AHA/ACC cholesterol guidelines into meaningful risk reduction.

J Fam Pract. 2019 May;68(4):206;210;212;214;217;221B.

Assessment of low-density lipoprotein targets.

Angiology. 2013 Aug;64(6):411-6. doi: 10.1177/0003319712451115. Epub 2012 Jun 25.

Individualized Risk Communication and Outreach for Primary Cardiovascular Disease Prevention in Community Health Centers: Randomized Trial.

Circ Cardiovasc Qual Outcomes. 2015 Nov;8(6):560-6. doi: 10.1161/CIRCOUTCOMES.115.001723. Epub 2015 Nov 10.

Prevention: HOPE-3 trial - targeting BP and LDL-C in at-risk patients.

Nat Rev Cardiol. 2016 May 16;13(6):315-6. doi: 10.1038/nrcardio.2016.74.

Statins for primary prevention: identifying low-risk individuals.

Nat Rev Cardiol. 2013 Sep;10(9):547. doi: 10.1038/nrcardio.2013.80-c1. Epub 2013 Jul 23.

Statins for primary prevention: problems with cardiovascular-risk estimation?

Nat Rev Cardiol. 2013 Sep;10(9):547. doi: 10.1038/nrcardio.2013.80-c2. Epub 2013 Jul 23.

Starting statins for primary prevention of cardiovascular disease.

Heart. 2013 Nov;99(21):1547-8. doi: 10.1136/heartjnl-2013-304284. Epub 2013 Jul 22.

Event reduction: revisiting why we treat with statins and harnessing current evidence towards optimal therapy.

Expert Opin Pharmacother. 2011 Jan;12(1):99-117. doi: 10.1517/14656566.2010.516747. Epub 2010 Nov 26.